A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Gag DNA Vaccine Alone or With IL-15 DNA, Boosted With HIV-1 Gag DNA + IL-15 DNA or HIV-1 Gag DNA + IL-12 DNA, in Healthy, HIV-1 Uninfected Adult Participants.
Phase of Trial: Phase I
Latest Information Update: 26 Mar 2012
At a glance
- Drugs HIV DNA vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 26 Mar 2012 Actual end date changed from Sep 2009 to July 2008 as reported by ClinicalTrials.gov.
- 29 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.